Similarly, the MD was consistently associated with a reduced risk of T2D across genders, with females showing improvements in insulin resistance and glucose metabolism, while males more often benefited from reductions in BW and BMI
The MHRA has licensed several GLP-1 agonists for use in the UK, and NICE guidelines (NG28) recommend them for specific patient groups, particularly those with type 2 diabetes who have not achieved adequate control with other medications or who have additional cardiovascular risk factors
While many nerve-related issues are reversible, they are uncomfortable and can cause distress for patients
"The questions are to the point and easy to navigate
Hydration and Blood Volume GLP-1s can sometimes reduce your sense of thirst
Serious but rare risks requiring immediate medical attention (call 999 or go to A&E if severe) include: Severe, persistent abdominal pain (potential pancreatitis) Signs of gallbladder problems (pain in upper right abdomen, fever, yellowing of skin or eyes) Chest pain, severe palpitations, or shortness of breath Severe mood changes or psychotic symptoms (more commonly associated with stimulants) Signs of severe dehydration or acute kidney injury Patients with pre-existing conditions require particular caution, including those with cardiovascular disease, history of pancreatitis, gallbladder disease, eating disorders, psychiatric conditions, or substance use history